{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:37Z","timestamp":1792783717281,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Innovation Centre (S&TIC)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbapap.2014.10.008","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T22:17:55Z","timestamp":1413411475000},"page":"547-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI)"],"prefix":"10.1016","volume":"1854","author":[{"given":"Robert","family":"Popp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Camenzind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Grace","family":"van der Gugten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pugia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jaremek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlev","family":"Suckau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H.","family":"Borchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2014.10.008_bb0005","series-title":"Global Status Report on Noncommunicable Diseases 2010","first-page":"1","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12020-011-9553-3","article-title":"Primary aldosteronism: from bench to bedside","volume":"41","author":"Sukor","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","article-title":"Primary aldosteronism: cardiovascular, renal and metabolic implications","volume":"19","author":"Rossi","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jso.23206","article-title":"Primary aldosteronism","volume":"106","author":"Carey","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","article-title":"The renin\u2013angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.HYP.25.3.443","article-title":"Locally generated angiotensin-II in the adrenal-gland regulates nasal, corticotropin-stimulated, and potassium-stimulated aldosterone secretion","volume":"25","author":"Gupta","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0050","series-title":"Rang & Dale's Pharmacology","author":"Rang","year":"2011"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.1964.03070160037008","article-title":"Suppression of plasma renin activity in primary aldosteronism \u2014 distinguishing primary from secondary aldosteronism in hypertensive disease","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2012-201287","article-title":"Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism","volume":"66","author":"Volpe","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0070","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0075","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone producing adenoma by measuring plasma renin activity results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0032-1314786","article-title":"Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism","volume":"44","author":"Willenberg","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(69)91237-9","article-title":"Radioimmunoassay determination of plasma-renin activity","volume":"1","author":"Boyd","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0095","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem-39-5-965","article-title":"Effects of pH and enzyme inhibitors on apparent generation of angiotensin I in human plasma","volume":"39","author":"Oparil","year":"1974","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinchem\/24.1.115","article-title":"Faster radioimmunoassay of angiotensin I at 37\u00b0C","volume":"24","author":"Fyhrquist","year":"1978","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjhyper.2003.08.015","article-title":"Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients","volume":"17","author":"Alderman","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1559-0275-10-20","article-title":"Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension","volume":"10","author":"Camenzind","year":"2013","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0115","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.4155\/bio.12.268","article-title":"Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC\u2013MS\/MS","volume":"4","author":"Chappell","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1258\/acb.2012.011186","article-title":"A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction","volume":"49","author":"Carter","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0125","first-page":"5","article-title":"LC\u2013MS\/MS in the clinical laboratory \u2014 where to from here?","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0130","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/prca.200700009","article-title":"Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis","volume":"1","author":"Jiang","year":"2007","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.aca.2007.10.025","article-title":"An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis","volume":"605","author":"Jiang","year":"2007","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0140","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.2144\/05386SU01","article-title":"A method for the absolute quantitation of cancer-related proteins using a MS-based peptide chip","volume":"38","author":"Warren","year":"2005","journal-title":"BioTechniques"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0145","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1373\/clinchem.2010.155705","article-title":"Improving the biomarker pipeline","volume":"56","author":"Borchers","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0150","article-title":"Methods of Quantitation and Identification of Peptides and Proteins","author":"Borchers","year":"2011"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0155","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/JCM.01881-09","article-title":"Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level","volume":"48","author":"Cherkaoui","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/1469-0691.12317","article-title":"Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK\u00ae MS system","volume":"20","author":"Garner","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mimet.2012.10.014","article-title":"Use of MALDI-TOF mass spectrometry for identification of bacteria that are difficult to culture","volume":"92","author":"Biswas","year":"2013","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0170","series-title":"MALDI Biotyper CA System","author":"Bruker Daltonics","year":"2013"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0175","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1074\/mcp.M800540-MCP200","article-title":"Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma","volume":"8","author":"Kuzyk","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0180","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/1471-2164-9-541","article-title":"A new strategy for faster urinary biomarkers identification by nano-LC\u2013MALDI-TOF\/TOF mass spectrometry","volume":"9","author":"Benkali","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0185","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/pr201092v","article-title":"Precision of heavy-light peptide ratios measured by MALDI-TOF mass spectrometry","volume":"11","author":"Anderson","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","article-title":"Plasma renin and aldosterone measurements in low renin hypertensive states","volume":"16","author":"Sealey","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0195","series-title":"Guidance for Industry \u2014 Bioanalytical Method Validation","author":"Food and Drug Administration","year":"2001"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0200","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1373\/clinchem.2010.146449","article-title":"Plasma renin activity by LC\u2013MS\/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity","volume":"56","author":"Bystrom","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2014.10.008_bb0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2009.09.018","article-title":"Pre-analytical and analytical considerations for the determination of plasma renin activity","volume":"410","author":"Brossaud","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbapap.2014.10.008_bb0210","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/clinchem\/37.10.1811","article-title":"Plasma renin activity and plasma prorenin assays","volume":"37","author":"Sealey","year":"1991","journal-title":"Clin. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963914002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963914002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T20:57:43Z","timestamp":1650401863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963914002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1570963914002684"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2014.10.008","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI)","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2014.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}